Literature DB >> 26603784

A Prospective Study of the Timing and Accuracy of Neutrophil Gelatinase-Associated Lipocalin Levels in Predicting Acute Kidney Injury in High-Risk Cardiac Surgery Patients.

Niall Fanning1, Sinead Galvin2, Rachael Parke2, James Gilroy3, Rinaldo Bellomo4, Shay McGuinness2.   

Abstract

OBJECTIVES: Neutrophil gelatinase-associated lipocalin (NGAL) appears to be a promising biomarker in the effort to predict acute kidney injury (AKI) after cardiac surgery. The authors aimed to identify the specific time point in the perioperative period at which measurement of either urinary or serum concentrations of NGAL would have the highest predictive power for AKI. The authors also investigated whether change in NGAL from baseline was a better predictor of AKI than absolute NGAL values.
DESIGN: A prospective, investigator-blinded observational study.
SETTING: The cardiac surgical unit of a university teaching hospital. PARTICIPANTS: The study consisted of 50 patients undergoing cardiac surgery who were classified preoperatively as high risk for developing postoperative AKI.
INTERVENTIONS: No changes to standard practice were required.
MEASUREMENTS AND MAIN RESULTS: The authors performed serial measurements of urinary and serum NGAL concentrations at 18 time points throughout the first 48 postoperative hours and assessed the variables required to diagnose AKI with standard criteria. Statistical analysis of predictive ability was performed using the area under receiver operator curves (AUROC) calculated for each time point. It was demonstrated that urinary NGAL performed marginally better than serum NGAL in predicting AKI. Urinary sampling at 4 and 24 hours after initiation of cardiopulmonary bypass provided the greatest diagnostic ability (AUROC, 0.702 and 0.712, respectively). Absolute NGAL values performed better than changes in NGAL values in predicting AKI.
CONCLUSIONS: Urinary NGAL performed better than serum NGAL in predicting AKI and was most accurate when measured at 24 hours after initiation of cardiopulmonary bypass; however, NGAL appeared to be at best only a fair predictor of cardiac surgery-associated AKI.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute kidney injury; biomarkers; cardiac surgery

Mesh:

Substances:

Year:  2015        PMID: 26603784     DOI: 10.1053/j.jvca.2015.07.034

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  5 in total

1.  Hemojuvelin Predicts Acute Kidney Injury and Poor Outcomes Following Cardiac Surgery.

Authors:  Sheng-Wen Ko; Nai-Hsin Chi; Che-Hsiung Wu; Tao-Min Huang; Shih-Chieh Jeff Chueh; Chih-Hsien Wang; Jui-Hsiang Lin; Wei-Jie Wang; Jui-Tsung Ting; Huang-Ming Chang; Rory Connolly; Chien-Heng Lai; Li-Jung Tseng; Vin-Cent Wu; Tzong-Shinn Chu
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

2.  Urinary Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Acute Kidney Injury, Severe Kidney Injury, and the Need for Renal Replacement Therapy in the Intensive Care Unit.

Authors:  Fatma I Albeladi; Haifa M Algethamy
Journal:  Nephron Extra       Date:  2017-07-12

3.  Novel renal markers for the assessment of renal integrity in patients undergoing knee arthroplasty - a pilot study.

Authors:  Annika Piirainen; Jukka Huopio; Hannu Kokki; Anu Holopainen; Teemu Pajunen; Kari Pulkki; Merja Kokki
Journal:  J Exp Orthop       Date:  2018-09-25

4.  Urine neutrophil gelatinase-associated lipocalin predicts outcome and renal failure in open and endovascular thoracic abdominal aortic aneurysm surgery.

Authors:  A Gombert; I Prior; L Martin; J Grommes; M E Barbati; A C Foldenauer; G Schälte; G Marx; T Schürholz; A Greiner; M J Jacobs; J Kalder
Journal:  Sci Rep       Date:  2018-08-23       Impact factor: 4.379

5.  Comparison of plasma neutrophil gelatinase-associated lipocalin (NGAL) levels after robot-assisted laparoscopic and retropubic radical prostatectomy: an observational study.

Authors:  Arzu Karaveli; Ali Sait Kavakli; Ozlem Cakin; Guzin Aykal; Ali Yildiz; Mutlu Ates
Journal:  Braz J Anesthesiol       Date:  2021-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.